Matches in Nanopublications for { ?s ?p "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP771868.RAlejwIXlLPIuPKtst6gXM8d1n9OK_flx2snUKM0VLfZ0130_assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771868.RAlejwIXlLPIuPKtst6gXM8d1n9OK_flx2snUKM0VLfZ0130_provenance.
- assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.
- NP1005800.RAu9-U97pvlNxnUeg9H-ZWAJfWkJbYj76AHRTrh1uqUk4130_assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005800.RAu9-U97pvlNxnUeg9H-ZWAJfWkJbYj76AHRTrh1uqUk4130_provenance.
- NP337421.RANyvJyDrlCcoZpHif486clYiHK0z4l0PKTIH0DlRXnSI130_assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337421.RANyvJyDrlCcoZpHif486clYiHK0z4l0PKTIH0DlRXnSI130_provenance.